|
Transgene seeks new taker for TG4010 as Novartis opts out
BioWorld Online Meanwhile, Oxford Biomedica plc also fell victim to big pharma’s predilection for pipeline prioritization. Paris-based Sanofi Group is handing back rights to its gene therapy program for wet age-related macular degeneration (AMD), Retinostat, which is … |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.